Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 13, 2021

SELL
$132.81 - $182.18 $10.8 Million - $14.8 Million
-81,104 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$138.17 - $184.34 $3.79 Million - $5.05 Million
-27,421 Reduced 25.27%
81,104 $14 Million
Q3 2020

Nov 13, 2020

BUY
$114.09 - $145.51 $1.69 Million - $2.16 Million
14,812 Added 15.81%
108,525 $15.1 Million
Q2 2020

Aug 14, 2020

BUY
$89.45 - $129.85 $5.1 Million - $7.41 Million
57,033 Added 155.49%
93,713 $11.2 Million
Q1 2020

May 14, 2020

SELL
$70.23 - $144.31 $689,237 - $1.42 Million
-9,814 Reduced 21.11%
36,680 $3.67 Million
Q4 2019

Feb 13, 2020

SELL
$76.41 - $117.54 $138,836 - $213,570
-1,817 Reduced 3.76%
46,494 $5.47 Million
Q3 2019

Nov 13, 2019

SELL
$61.52 - $91.1 $774,536 - $1.15 Million
-12,590 Reduced 20.67%
48,311 $4.15 Million
Q2 2019

Aug 08, 2019

BUY
$58.04 - $66.99 $1.94 Million - $2.24 Million
33,477 Added 122.07%
60,901 $3.95 Million
Q1 2019

May 13, 2019

SELL
$35.52 - $62.62 $344,579 - $607,476
-9,701 Reduced 26.13%
27,424 $1.71 Million
Q4 2018

Feb 14, 2019

SELL
$35.43 - $56.29 $8.18 Million - $13 Million
-230,972 Reduced 86.15%
37,125 $1.44 Million
Q3 2018

Nov 13, 2018

SELL
$44.22 - $75.47 $2.58 Million - $4.41 Million
-58,374 Reduced 17.88%
268,097 $15.3 Million
Q2 2018

Aug 13, 2018

BUY
$72.38 - $92.5 $3.63 Million - $4.63 Million
50,097 Added 18.13%
326,471 $26.1 Million
Q1 2018

May 14, 2018

BUY
$69.46 - $88.57 $1.03 Million - $1.31 Million
14,813 Added 5.66%
276,374 $24 Million
Q4 2017

Feb 13, 2018

BUY
$65.94 - $93.31 $12.3 Million - $17.4 Million
186,753 Added 249.64%
261,561 $18.1 Million
Q3 2017

Nov 13, 2017

BUY
$80.87 - $91.08 $5.15 Million - $5.8 Million
63,629 Added 569.18%
74,808 $6.8 Million
Q2 2017

Aug 14, 2017

SELL
N/A
-858 Reduced 7.13%
11,179 $832,000
Q1 2017

Apr 17, 2019

SELL
N/A
-79,142 Reduced 86.8%
12,037 $1.13 Million
Q3 2016

Apr 17, 2019

BUY
N/A
91,179
91,179 $9.52 Million

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $133M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Allianz Asset Management Gmb H Portfolio

Follow Allianz Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.